Serum Apolipoprotein C-III and Cardiovascular Events in Type 1 Diabetes

被引：0
|
作者：
Basu, Arpita
Bebu, Ionut
Jenkins, Alicia
Stoner, Julie
Zhang, Ying
Klein, Richard L.
Lopes-Virella, Maria F.
Garvey, W. Timothy
Budoff, Matthew
Lyons, Timothy
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-188-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis
    Rowell, J.
    Thompson, A. J.
    Guyton, J. R.
    Lao, X. Q.
    McHutchison, J. G.
    McCarthy, J. J.
    Patel, K.
    HEPATOLOGY INTERNATIONAL, 2012, 6 (02) : 475 - 481
  • [32] Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis
    J. Rowell
    A. J. Thompson
    J. R. Guyton
    X. Q. Lao
    J. G. McHutchison
    J. J. McCarthy
    K. Patel
    Hepatology International, 2012, 6 : 475 - 481
  • [33] INCREASED PLASMA APOLIPOPROTEIN C-III CONCENTRATION PREDICTS CARDIOVASCULAR MORTALITY: THE HOORN STUDY
    Scheffer, P. G.
    Teerlink, T.
    Dekker, J. M.
    G, B.
    Nijpels, G.
    Diamant, M.
    Kostense, P. J.
    Stehouwer, C. D. A.
    Heine, R. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 10 - 10
  • [34] High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin
    Olivieri, Oliviero
    Turcato, Gianni
    Cappellari, Manuel
    Stefanoni, Filippo
    Osti, Nicola
    Pizzolo, Francesca
    Friso, Simonetta
    Bassi, Antonella
    Castagna, Annalisa
    Martinelli, Nicola
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [35] Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III
    Martin-Gonzalez, C.
    Martin-Folgueras, T.
    Quevedo-Abeledo, J. C.
    de Armas-Rillo, L.
    Gonzalez-Gay, M. A.
    Ferraz-Amaro, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (01) : 67 - 73
  • [36] Apoprotein C-III (ApoCIII) protein concentrations and gene polymorphisms in Type 1 diabetes
    Klein, RL
    Hunter, SJ
    Jenkins, AJ
    Zheng, DY
    Le, NA
    Brown, V
    Garvey, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A50 - A50
  • [37] Serum Apolipoprotein C-III in HDL: Key Diabetogenic Risk Factor among Turks
    Hergenc, G.
    Onat, A.
    Ayhan, E.
    Ugur, M.
    Kaya, H.
    Tuncer, M.
    Can, G.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A87 - A87
  • [38] APOLIPOPROTEIN C-II AND C-III LEVELS IN HYPERLIPOPROTEINEMIA
    SCHONFELD, G
    GEORGE, PK
    MILLER, J
    REILLY, P
    WITZTUM, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (10): : 1001 - 1010
  • [39] Administration of a PPARα agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio
    Schultze, AE
    Alborn, WE
    Newton, RK
    Konrad, RJ
    JOURNAL OF LIPID RESEARCH, 2005, 46 (08) : 1591 - 1595
  • [40] Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III
    de Messieres, Michel
    Huang, Rick K.
    He, Yi
    Lee, Jennifer C.
    BIOCHEMISTRY, 2014, 53 (20) : 3261 - 3263
12345